SANJAY KUMAR KEDIAversusNARCOTICS CONTROL BUREAU & ANR.
- Citation
- 2007 INSC 1216
- Decided
- 3 December 2007
- Disposal
- Dismissed
- Bench
- S B SINHA
Holding
Section 79 of the IT Act does not shield a person who, through his website, actively facilitates the supply of psychotropic substances, and therefore the appellant is not entitled to bail under Section 37 of the NDPS Act.
Summary
Sanjay Kumar Kedia incorporated two companies, Xponse Technologies Ltd and Xponse IT Services Pvt Ltd, which were alleged to have used their internet platforms to arrange the supply of psychotropic drugs such as phentermine and butalbital to customers abroad. The Narcotics Control Bureau investigated, seized assets and arrested Kedia, who subsequently filed multiple bail applications that were rejected by the High Court and the Special Judge. Kedia contended that his firms were merely neutral network service providers protected by Section 79 of the Information Technology Act, 2000, and therefore entitled to immunity from prosecution under the NDPS Act. The Supreme Court examined the evidence, finding that the companies operated as online pharmacies and actively facilitated illegal drug transactions, and that Section 79 immunity applies only to offences under the IT Act itself. Consequently, the Court held that the appellant was not an innocent intermediary, and the overwhelming evidence precluded the grant of bail under Section 37 of the NDPS Act. The appeal against the bail denial was dismissed.
Issues considered
- Whether the appellant's companies qualify as "intermediaries" under Section 79 of the Information Technology Act, 2000 and are thus immune from prosecution for offences under other statutes.
- Whether the alleged conduct constitutes an offence under Sections 24 and 29 of the Narcotic Drugs and Psychotropic Substances Act, 1985.
- Whether bail can be granted to the appellant under Section 37 of the NDPS Act in view of the evidence of his involvement.
Legislation cited
- Information Technology Act, 2000s. 79
- Narcotic Drugs and Psychotropic Substances Act, 1985s. 24, s. 29, s. 37, s. 8
Subjects
Judgment
A SANJA Y KUMAR KEDIA
v.
NARCOTICS CONTROL BUREAU & ANR.
DECEMBER 3, 2007
B
[S.B. SINHA AND HARJIT SINGH BEDI, JJ.]
Narcotic Drugs and Psychotropic Substances Act: 1985:
C s. 37-Applicationfor bail-Companies providing network
facilities/or arranging supply of banned psychotropic substance on
line-Owner arrested u/ss. 24 and 29-Plea of applicant that his
companies were protected from prosecution by s. 79 of Information
Technology Act-Held: Applicant and his associates were not innocent
D intermediaries or network service providers as defined under s. 79 of
1. T. Act but the said business was only a facade and comoujlage for
more sinister activity-In this situation, s. 79 will not grant immunity
to an accused who has violated provisions ofthe Act as this provision
gives immunity from prosecution for an offence only under I. T. Act
itself-In the face of overwhelming inculpatory evidence it is not
E possible to give finding envisaged under s. 37 of the Act for grant of
bail that there were reasonable grounds for believing that applicant
was not guilty of offence alleged, or that he would not resume his
activities should bail be granted-Information Technology Act, 2000-
s. 79.
F
CRIMINAL APPELLATE JURISDICTION : Criminal Appeal No.
1659 of2007.
From the Judgment and final Order dated 07.06.2007 of the High
Court at Calcutta in CRM No. 5124 of 2007.
G
K.T.S. Tulsi and Uday Umesh Lalit, Arun Kumar Srivasma, Manoj
Prasad, Amit Pawan and G. Bhargava for the Appellant.
Vikas Singh, ASG., B.B. Singh, Binu Tamta and Sushma Suri for
H the Respondents.
812
SANJAY KUMAR KEDIA v: NARCOTICS CONTROL 813
BUREAU [HARflT SINGH BEDI, J.]
The following Order of the Court was delivered by A
ORDER
HARJIT SINGH BEDI, J. 1. Special Leave granted.
2. The appellant Sanjay Kumar, Kedia, a highly qualified individual,
set up two companies Mis. Xponse Technologies Limited (XTL) and B
Mis. Xponse IT Services Pvt. Ltd. (XIT) on 22.4.2002 and 8.9.2004
respectively which were duly incorporated under the Indian Companies
Act, 1956. On 1.2.2007 officers of the Narcotics Control Bureau (NCB)
conducted a search at the residence and office premises of the appellant
but found nothing incriminating. He was also called upon to appear before C
the NCB on a number of occasions pursuant to a notice issued to him
under Section 67 of the Narcotic Drugs and Phychotropic Substances
Act, 1985 (hereinafter referred to as the "Act") and was ultimately
arrested and the bank accounts and premises of the two companies were
also seiz.ed or sealed. On 13.3.2007 the appellant filed an application for D
bail in the High Court which was dismissed on the ground that a prima
facie case under Sections 24 and 29 of the Act had been made out and
that the investigation was yet not complete. The appellant thereafter moved
a second bail application. before the High Court on 16.4.2007 which too
was dismissed with the observations that the enquiry was at a critical stage E
and that the department should be afforded sufficeint time to conduct its
enquiry and to bring it to its logical conclusion as the alleged offences had
widespread ramifications for society. It appears that a bail application was
thereafter filed by the appellant before the Special Judge which too was
rejected on 28.5.2007 with the observations that the investigation was F
still in progress. Aggrieved thereby, the appellant preferred yet another
application for bail before the High Court on 4.6.2007 which too was
dismissed on 7.6.2007. The present appeal has been filed against this
order.
3. Notice was issued on the Special Leave Petition on 30.7.2007 G
by a Division Bench noticing a contention raised by Mr. Tulsi that service
providers such as the two companies which were intermediaries were
protected from prosecution by Section 79 of the Information Technology
Act, 2000. An affidavit in reply has also been filed on behalf of the
H
814 SUPREME COURT REPORTS [2007] 12 S.C.R.
A respondent - NCB and a rejoinder affidavit in reply thereto by the
appellant.
4. We have heard learned cotinsel for the parties at length.
5. Mr. Tulsi has first and foremost argued that the allegations against
B the appellant were that he had used the network facilities provided by his
companies for arranging the supply of banned psychotropic substances
on line but there was no evidence to suggest that the appellant had been
involved in dealing with psychotropic substances or engaged in or
controlled any ):fade whereby such a substance obtained outside India had
c been supplied to persons outside India and as such no case under Section
24 of the Act had been made out against the appellant. Elaborating this
argument, he has submitted that the two drugs which the appellant had
allegedly arranged for supply were phentermine and butalbital and as these
drugs were not included in Schedule-I of the Narcotic Drugs or
D Psychotropic Substances Rules 1987 in terms of the notification dated
21.2.2003 and were also recognized by the Control Substances Act, a
law applicable in the United States, as having low protential for misuse
and it was possible to obtain these drugs either on written or oral
prescription of a doctor, the supply of these drugs did not fall within the
E mischief of Section 24. He has further argued that in the circumstance,
the companies were mere network service providers they were protected
under Section 79 of the Technology Act from any prosecution.
6. Mr. Vikas Singh, the learned Additional Solicitor General for the
respondents has however pointed out that the aforesaid drugs figured in
F the Schedule appended to the Act pertaining to the list of psychotropic
substances (at Sri. Nos. 70 and 93) and as such it was clear that the two
drugs were psychotropic substances and therefore subject to the Act. It
has also been pointed out that the appellant had been charged for offence
under Sections 24 and 29 of the Act which visualized that a person could
G be guilty without personally hadling a psychotropic substance and the
evidence so far collected showed that the appellant was in fact a facilitator
between buyers and certain pharmacies either owned or controlled by
him or associated with the two companies and that Section 79 of the
Technology Act could not by any stretch of imagination guarantee immunity
H
j
SANJA Y KUMAR KEDIA v. NARCOTICS CONTROL 815
BUREAU[HARJITSINGHBEDI,J.]
from prosecution under the provisions of the Act. A
7. It is clear from the Schedule to the Act that the two drugs
phentermine and butalbital are psychotropic substances and therefore fall
within the prohibition contained in Section 8 thereof. The appellant has
been charged for offences punishable under Section 24 and 29 of the Act.
These Sections are re-produced below: B
24. "Punishment for external dealings in narcotic drugs and
psychotropic substances in contravention of section J2.-
Whoever engages in or controls any trade whereby a narcotic drug
or a psychotropic substance is obtained outside India and supplied c
to any person outside India without the previous authoriz.ation of
the Central Government or otherwise than in accordance with the
conditions (if any) of such authoriz.ation granted under section 12,
shall be punsihable with rigorous imprisonment for a term which
shall not be less than ten years but which may extend to twenty D
years and shall also be liable to fine which shall not be less than
one lakh mpees but may extend to two lakh mpes:
Provided that the court may, for reasons to be recorded in the
judgment, imose a fine exceeding two lakj rupees".
E
29. Punishment for abetment and Criminal conspiracy. - (1)
Whoever abets, or is a pa.ti to a criminal conspirac to commit an
offence punishable under this Chapter, shall, whether such offence
be or be not committed in consequence of such abetment or in
pursuance of such criminal conspiracy, and notwithstanding anything F
contained in section 116 of the Indian Penal Code (45of1860),
be punishable with the punishment provided for the offence.
(2) A person abets, or is a party to a criminal conspiracy to commit,
an offence, within the meaning of this section, who, in India abets
or is a partyto the criminal conspiracy to the commission of any G
act in a place without and beyond India which -
7
(a) would constitute an offence if committed within India: or
(b) under the laws of such place, is an offence relating to narcotic
drugs or psychotropic substances having all the legal conditions H
816 SUPREME COURT REPORTS [2007] 12 S.C.R.
A required to constitute it such an offence the same as or
analogous to the legal conditions required to constitute it an
offence punishable under this Chapter, if committed within
India
B 8. A perusal of Section 24 woulod show that it deals with the
engagement or control of a trade in Narcotic Drugs and Psychotropic
substances controlled and supplied outside India and Section 29 provides
for the penalty arising out of an abetrnent or criminal conspiracy to commit
an offfence under Chapter IV which includes Section 24. We have
accordingly examined the facts of the case in the light of the argument of
C Mr. Tulsi that the companies only provided third party data and infotmation
without any knowledge as to the commission of an offence under the Act.
We have gone through the affidavit ofShri A.P. Siddiqui Deputy Director,
NCB and reproduce the conclusions drawn on the investigation, in his
words.
D
"(i) The accused and its associates are not intetmediary as defined
under Section 79 of the said Act as their acts and deeds was not
simply restricted to provision of third party data or information
without having knowledge as to commission of offece under the
E NDPS Act. The company (Xponse Technologies Ltd. And Xpose
IT Services Pvt. Ltd. Headed by Sanjay Kedia) has designed,
developed, hosted the phatmaceutical websites and was using these
websites, huge quantity of psychotropic substances (Phentermine
and Butalbital) have been distributed in USA with the help of his
associates. Following are the online phatmacy website which are
F
owned by Xponse or Sanjay Kedia.
(1) Brother Phacmacy.Com and LessRx.Com: Brothers
phatmacy.com, online phatmacy was identified as a marketing
website (front end) for phannaceutical drugs. LessRx..com has
G been identified as a "back end" site which was being utilized
to process orders for pharmaceutical drugs through
Brotherpharmacy.com. LessRx.com's registrant and
administrative contract was listed True Value Phatmacy located
at 29B, Rabindra Sarani, Kolkata, India-700073. Telephone
H No. 033-2335-7621 which is the address is 203.86.100.95.
SANJAYKUMARKEDIAv. NARCOTICS CONTROL 817
BUREAU[HARJITSINGHBEDI,J.]
The following websites were also utilizing this IP address: A
ALADIESPHARMACY.com,
EXPRESSPHENTERMINE.com,
FAMIL YYONLINEPHARMACY.com,
B
ONLINEEXPRESSPHARMACY.com,
SHIPPEDLIPITOR.com
Domain name Servers for LessRx.com (IP address:
203.86.100.95) were NS. PALCOMONLINE.com and C
NS2PALCOMLINE.com.
The LessRx.com's website hosting company was identified as
Pacom Web Pvt Ltd, C-56/14, I st Floor, Institutional Area, Sector
62, Noida-201301. Sanjay Kedia entrusted the hosting work to D
Palcom at VSNL, Delhi. These servers have been seized. Voluntary
statement ofShri Ashish Chaudhary, Prop. of Palcom Web Pvt
Ltd. indicates that He maintained the websites on behal ofXponse.
According to the bank records, funds have been wired from
Brothers pharmacy, Inc's Washington Mutual Bank Account E
#0971709674 to Xponse It services Pvt Ltd, ABN AMRO bank
account No. 1029985, Kolkata.
(2) Deliveredmedicine.com : A review of the Xponse' s website-
XPONSEIT.com was conducted and observed and advertisement
for XPONSERX. That XPONSERX was described as a software F
platform developed for the purpose of powering online pharmacies.
Xponserx was designed to process internet pharmacy orders. Drug
Enforcement Administration (DEA), USA conducted a "whois"
reverse lookup on domain name XPONSERX.COM was at
domaintools.com was at domaintools.Com was registered to G
XPonse IT Services Pvt Ltd, Sanjay Kedia, 29B, Rabindra Sarani,
12E, 3rd floor, Kolkata, WB 70073. Telephone no.91-
9830252828 was also provided for Xponse. Two websites were
also provided for Xponse. Two websites were featured on the
H
818 SUPREME COURT REPORTS [2007] 12 S.C.R.
A XPONSEIT.COM websites as featured clients. And these were
DELIVEREDMEDICINE.COM AND
TRUEV ALUEPRESCRIPTIONS.COM. Review indicated that
these two websites were internet phannacies.
Consequently a "whois" reverse look-up on domain name
B
DELIVEREDMEDICINE.COM at domainstools. com conducted
by DEA revealed that it was registered to Xponse Inc., 2760 Park
Ave., Santa Clara, CA, USA which is the address of Sanjay
Kedia.
c (3) Truevalueprescriptions.com: Review of this website indicated
that this website was TRUEV ALUEPRESCRIPTIONS listed
Phentermine as a drug available for sale. It appeared that orders
for drugs could be made without a prescription from the
TRUEVALUE website, it was noted that orders for drugs could
D be placed without seeing a doctor. According to the website, a
customer can complete an online questionnaire when placing the
order for a drug in liew of a physical exam in a physician's office.
Toll free telephone number 800-590-5942 was provided on the
TRUEVALUE website for customer Service.
E DEA, conducted a "whosi" reverse look-up on domain name
TRUEVALUEPRESCRIPTIONS.COM at domaintools.com and
revealed that IP address was 203 .86.100. 76 and the server that
hosts the website was located at Palcom, Delhi which also belongs
to Xponse.
F
From the aboce facts it is clear that the Xponse Tecnologies Ltd
and Xponse IT Services Pvt Ltd were not acting merely as a
network service provider but were actually running internet
pharmacy and dealing with prescription drugs like Phentermine and
Butalbital."
G
9. We thus find that the appellant and his associates were not
innocent intermediaries or network service providers as defined under
Section 79 of the Technology Act but the said business was only a facade
and camouflage for more sinister activity. In this situation, Section 79 will
H
SANJA Y KUMAR KEDIA v. NARCOTICS CONTROL 819
r BUREAU[HARJITSINGHBEDI,J.]
not grant immunity to an accused who has violated the provisions of the A
Act as this provision gives immunity from prosecution for an offence only
under Technology Act itself.
10. We are therefore of the opinion that in the face of overwhelming
inculpatory evidence it is not possible to give the finding envisaged under
Section 3 7 of the Act for the grant of bail that there were reasonable B
grounds for believing that the appellant was not guilty of the offence
alleged, or that he would not resume his activities should bail be granted.
11. For the reasons recorded above, we find no merit in this appeal,
which is accordingly dismissed. We however qualify that the observations c
made above are in the context of the arguments raised by the learned
counsel on the bail matter which obligated us to deal with them, and will
not influence the proceedins or decision in the trial in any manner.
RP. Appeal dismissed.
Search Indian case law
Ask in plain English, not just keywords. 25,000 AI words free, no card.